These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34690091)
1. Clinical Characteristics, Prognosis, and Treatment Strategies of TP53 Mutations in Myelodysplastic Syndromes. Fang K; Qi J; Zhou M; Zhang Z; Han Y Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):224-235. PubMed ID: 34690091 [TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation. Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108 [TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysis. Deng J; Wu X; Ling Y; Liu X; Zheng X; Ye W; Gong Y Eur J Haematol; 2020 Nov; 105(5):524-539. PubMed ID: 32621334 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents. Takahashi K; Patel K; Bueso-Ramos C; Zhang J; Gumbs C; Jabbour E; Kadia T; Andreff M; Konopleva M; DiNardo C; Daver N; Cortes J; Estrov Z; Futreal A; Kantarjian H; Garcia-Manero G Oncotarget; 2016 Mar; 7(12):14172-87. PubMed ID: 26871476 [TBL] [Abstract][Full Text] [Related]
5. Role Of TP53 mutations in predicting the clinical efficacy of hypomethylating therapy in patients with myelodysplastic syndrome and related neoplasms: a systematic review and meta-analysis. Cai L; Zhao X; Ai L; Wang H Clin Exp Med; 2020 Aug; 20(3):361-371. PubMed ID: 32613269 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and characteristics of patients with Zhang L; Chen K; Li Y; Chen Q; Shi W; Ji T; Tao H; He Z; Wang C; Yu L Hematology; 2023 Dec; 28(1):2181773. PubMed ID: 36892252 [TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50]. Zeng YP; Li B; Qin TJ; Xu ZF; Qu SJ; Pan LJ; Gao QY; Jiao M; Wu JY; Wang HJ; Li CW; Ja YJ; Sun Q; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2024 Jul; 45(7):651-659. PubMed ID: 39231769 [No Abstract] [Full Text] [Related]